Riskpilot
← Back to search
Sign in
Get full access
SinSa Labs Aktiebolag
AB
Active
Org 5590719489
Manufacture of pharmaceutical preparations
· NACE 2120
Est. 2016
0 employees
Watchlist
Share
Sweden
/
Companies
/
Manufacture of pharmaceutical preparations
/
SinSa Labs Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
Revenue 2024
SEK 0
EBITDA margin
—
-11% vs 2023
Equity ratio
56.8%
Financial strength
Net profit 2024
SEK -84K
-2% vs 2023
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
SEK 0
—
EBITDA
SEK -20K
-11%
Net profit
SEK -84K
-2%
Total assets
SEK 5M
+0%
Equity
SEK 2,9M
-3%
Employees
0
—
Company information
Legal name
SinSa Labs Aktiebolag
Org number
5590719489
Legal form
Aktiebolag
NACE code
2120 ·
Manufacture of pharmaceutical preparations
Founded
4 augusti 2016
Share capital
SEK 60 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Registrerad kvalificerad revisor saknas.
Company purpose
Bolaget ska ha till verksamhet att utveckla, tillverka och marknadsföra läkemedel och medicinteknik samt därmed förenlig verksamhet.
Contact
Address
Email
urban@advokatuo.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Manufacture of pharmaceutical preparations
Companies in Stockholm
All Sweden companies
Frequently asked questions
What is the Org number of SinSa Labs Aktiebolag?
SinSa Labs Aktiebolag is registered with Bolagsverket / SCB under Org 5590719489.
Who is the CEO of SinSa Labs Aktiebolag?
Lennart Ingemar Rindstig is Audit of SinSa Labs Aktiebolag, in role since 2021.
Who is the chairman of SinSa Labs Aktiebolag?
Bengt Urban Robert Olsson chairs the board of SinSa Labs Aktiebolag, in role since 2020.
Riskpilot